Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115,244,363
-
Total 13F shares
-
112,752,353
-
Share change
-
+1,363,778
-
Total reported value
-
$7,722,130,519
-
Put/Call ratio
-
21%
-
Price per share
-
$68.49
-
Number of holders
-
444
-
Value change
-
+$131,340,892
-
Number of buys
-
198
-
Number of sells
-
218
Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q2 2024
As of 30 Jun 2024,
GLOBUS MEDICAL INC - Class A Stock (GMED) was held by
444 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
112,752,353 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., JANUS HENDERSON GROUP PLC, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, Bank of New York Mellon Corp, Burgundy Asset Management Ltd., Camber Capital Management LP, and Champlain Investment Partners, LLC.
This page lists
445
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.